WST · West Pharmaceutical Services Inc
$349.42
+3.26 (+0.94%)
At close · Aug 14
Market Cap
$24.83B
Shares
70.38M
West Pharmaceutical Services Inc Earnings Call Transcripts
Every quarterly earnings call for West Pharmaceutical Services Inc (WST) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▼2.8%
$686.90M
$120.60M
'22 Q3
22-10-27
▼3%
$708.70M
$103.00M
'22 Q4
23-02-16
▼0.5%
$716.60M
$140.00M
'23 Q1
23-04-27
▼2.3%
$753.80M
$155.10M
'23 Q2
23-07-27
▲8.8%
$747.40M
$161.30M
'23 Q3
23-10-26
▲3.3%
$732.00M
$137.00M
'23 Q4
24-02-15
▼3%
$695.40M
$115.30M
'24 Q1
24-04-25
▼6.9%
$702.10M
$111.30M
'24 Q2
24-07-25
▼0.1%
$746.90M
$136.00M
'24 Q3
24-10-24
▲2.3%
$748.80M
$130.10M
'24 Q4
25-02-13
▲0.4%
$698.00M
$89.80M
'25 Q1
25-04-24
▲9.2%
$766.50M
$131.80M
'25 Q2
25-07-24
▲7.7%
$804.60M
$140.00M
'25 Q3
25-10-23
▲7.5%
$805.00M
$132.10M
'25 Q4
26-02-12
▲21%
$844.90M
$138.80M
'26 Q1
26-04-23
LATEST
▲13.8%
$872.30M
$154.00M
'26 Q2
26-07-23
Earnings call
FY26 · Q2
2026-07-23
West Pharmaceutical Services Inc Q2 FY2026 Earnings Call
Confident tone
GLP-1 Demand
Proprietary Products / HVP Components Growth
Annex 1 / HVP Upgrade Mix Shift
Revenue
$872.30M
▲ 13.8% YoY Diluted EPS
$2.15
▲ 18.1% YoY Gross margin
37.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q1
2026-04-23
West Pharmaceutical Services Inc Q1 FY2026 Earnings Call
Confident tone
HVP Components / Proprietary Products
GLP-1 and Orals Market
Regulatory Tailwinds (Annex 1)
Revenue
$844.90M
▲ 21% YoY Diluted EPS
$1.92
▲ 56.1% YoY Gross margin
35.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-02-12
West Pharmaceutical Services Inc Q4 FY2025 Earnings Call
Confident tone
Proprietary Products / HVP components growth
GLP-1 market dynamics
Capacity expansion and tech transfers
Revenue
$805.00M*
▲ 7.5% YoY Gross margin
37.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-10-23
West Pharmaceutical Services Inc Q3 FY2025 Earnings Call
Confident tone
Organic revenue growth and raised guidance
Annex 1 regulatory upgrade opportunity
HVP components / proprietary segment strength
Revenue
$804.60M
▲ 7.7% YoY Diluted EPS
$1.92
▲ 3.8% YoY Gross margin
36.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-07-24
West Pharmaceutical Services Inc Q2 FY2025 Earnings Call
Confident tone
HVP Components and GLP-1 Growth
Annex-1 Opportunity
SmartDose and HVP Delivery Devices
Revenue
$766.50M
▲ 9.2% YoY Diluted EPS
$1.82
▲ 20.5% YoY Gross margin
35.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-04-24
West Pharmaceutical Services Inc Q1 FY2025 Earnings Call
Positive tone
Proprietary Products / HVP components
Biologics destocking and recovery
Contract-manufactured products
Revenue
$698.00M
▲ 0.4% YoY Diluted EPS
$1.23
▼ 20.6% YoY Gross margin
33.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-02-13
West Pharmaceutical Services Inc Q4 FY2024 Earnings Call
Positive tone
GLP-1 market growth
HPP components and biologics
Contract manufacturing strategy shift
Revenue
$748.80M*
▲ 2.3% YoY Gross margin
36.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-10-24
West Pharmaceutical Services Inc Q3 FY2024 Earnings Call
Positive tone
Biologics and HVP
De-stocking normalization
Drug delivery devices ramp
Revenue
$746.90M
▼ 0.1% YoY Diluted EPS
$1.85
▼ 13.6% YoY Gross margin
35.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-07-25
West Pharmaceutical Services Inc Q2 FY2024 Earnings Call
Cautious tone
Proprietary Products and Biologics
Customer destocking and order patterns
Capacity expansion and capital projects
Revenue
$702.10M
▼ 6.9% YoY Diluted EPS
$1.51
▼ 26.7% YoY Gross margin
32.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-04-25
West Pharmaceutical Services Inc Q1 FY2024 Earnings Call
Positive tone
Customer destocking and inventory management
Contract Manufacturing / GLP-1 demand
HVP components and devices (Proprietary Products)
Revenue
$695.40M
▼ 3% YoY Diluted EPS
$1.55
▼ 16.2% YoY Gross margin
33.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-02-15
West Pharmaceutical Services Inc Q4 FY2023 Earnings Call
Cautious tone
Capital expenditure deployment
HVP (High-Value Product) capacity expansion
2024 guidance reduction and headwinds
Revenue
$732.00M*
▲ 3.3% YoY Gross margin
38.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-10-26
West Pharmaceutical Services Inc Q3 FY2023 Earnings Call
Revenue
$747.40M
▲ 8.8% YoY Diluted EPS
$2.14
▲ 34.6% YoY Gross margin
38.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-07-27
West Pharmaceutical Services Inc Q2 FY2023 Earnings Call
Revenue
$753.80M
▼ 2.3% YoY Diluted EPS
$2.06
▼ 16.9% YoY Gross margin
38.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-04-27
West Pharmaceutical Services Inc Q1 FY2023 Earnings Call
Revenue
$716.60M
▼ 0.5% YoY Diluted EPS
$1.85
▼ 19.2% YoY Gross margin
37.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-02-16
West Pharmaceutical Services Inc Q4 FY2022 Earnings Call
Revenue
$708.70M*
▼ 3% YoY Gross margin
37.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-10-27
West Pharmaceutical Services Inc Q3 FY2022 Earnings Call
Revenue
$686.90M
▼ 2.8% YoY Diluted EPS
$1.59
▼ 31.2% YoY Gross margin
39.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-07-28
West Pharmaceutical Services Inc Q2 FY2022 Earnings Call
Revenue
$771.30M
▲ 6.6% YoY Diluted EPS
$2.48
▲ 0.4% YoY Gross margin
41.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-04-28
West Pharmaceutical Services Inc Q1 FY2022 Earnings Call
Revenue
$720.00M
▲ 7.4% YoY Diluted EPS
$2.29
▲ 15.1% YoY Gross margin
39.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-02-17
West Pharmaceutical Services Inc Q4 FY2021 Earnings Call
Revenue
$730.80M*
▲ 26% YoY Gross margin
41.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-10-28
West Pharmaceutical Services Inc Q3 FY2021 Earnings Call
Revenue
$706.50M
▲ 28.9% YoY Diluted EPS
$2.31
▲ 111.9% YoY Gross margin
40.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-07-29
West Pharmaceutical Services Inc Q2 FY2021 Earnings Call
Revenue
$723.60M
▲ 37.3% YoY Diluted EPS
$2.47
▲ 104.1% YoY Gross margin
43.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-04-29
West Pharmaceutical Services Inc Q1 FY2021 Earnings Call
Revenue
$670.70M
▲ 36.5% YoY Diluted EPS
$1.99
▲ 101% YoY Gross margin
40.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-02-18
West Pharmaceutical Services Inc Q4 FY2020 Earnings Call
Revenue
$580.20M
▲ 23.3% YoY Diluted EPS
$1.29
▲ 53.6% YoY Gross margin
36.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-10-22
West Pharmaceutical Services Inc Q3 FY2020 Earnings Call
Revenue
$548.00M
▲ 20.1% YoY Diluted EPS
$1.09
▲ 45.3% YoY Gross margin
35.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-07-23
West Pharmaceutical Services Inc Q2 FY2020 Earnings Call
Revenue
$527.20M
▲ 12.2% YoY Diluted EPS
$1.21
▲ 37.5% YoY Gross margin
37.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-04-23
West Pharmaceutical Services Inc Q1 FY2020 Earnings Call
Revenue
$491.50M
▲ 10.8% YoY Diluted EPS
$0.99
▲ 35.6% YoY Gross margin
34.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-02-13
West Pharmaceutical Services Inc Q4 FY2019 Earnings Call
Revenue
$470.60M
▲ 11.4% YoY Diluted EPS
$0.84
Gross margin
32.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–27 of 27 earnings calls